Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Prexasertib works in select patients with recurrent ovarian cancer
14 Oct 2022
CHK1 inhibition with prexasertib appears to have durable activity in some patients with recurrent ovarian cancer regardless of clinical characteristics, BRCA status, or prior therapies, according to the results of a phase II trial.
Prexasertib works in select patients with recurrent ovarian cancer
14 Oct 2022
Sotagliflozin may offer cardiorenal protection for adults with T1D
13 Oct 2022
bởiAudrey Abella
Using the Steno T1 Risk Engines, the dual SGLT*1 and SGLT2 inhibitor sotagliflozin showed potential in reducing the risk of cardiovascular (CV) and renal disease in adults with type 1 diabetes (T1D).
Sotagliflozin may offer cardiorenal protection for adults with T1D
13 Oct 2022
Early noninferior to delayed NOAC initiation after stroke in AF patients
13 Oct 2022
Early initiation of nonvitamin K antagonist oral anticoagulants (NOACs) after acute ischaemic stroke in patients with atrial fibrillation (AF) appears to yield similar outcomes when compared with delayed initiation, as shown in the results of the TIMING* study.